Jerome Groopman | Academic Influence

Jerome Groopman's AcademicInfluence.com Rankings

Jerome Groopman

Philosophy

#4466

Historical Rank

Logic

#1295

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jerome Groopman's Degrees

Masters Medicine Columbia University

Why Is Jerome Groopman Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jerome E. Groopman has been a staff writer in medicine and biology for The New Yorker since 1998. He is the Dina and Raphael Recanati Chair of Medicine at Harvard Medical School, Chief of Experimental Medicine at Beth Israel Deaconess Medical Center, and author of five books, all written for a general audience.

(See a Problem?)

Jerome Groopman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. (1987) (2759)
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. (1987) (1503)
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. (2000) (1178)
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. (1985) (1023)
Chemotherapy-induced anemia in adults: incidence and treatment. (1999) (913)
HTLV-III infection in brains of children and adults with AIDS encephalopathy. (1985) (857)
Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. (1997) (822)
The α-Chemokine, Stromal Cell-derived Factor-1α, Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways* (1998) (645)
Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression (1989) (593)
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. (1987) (568)
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. (1984) (556)
Designing CD4 immunoadhesins for AIDS therapy (1989) (466)
Hematopoietic growth factors. Biology and clinical applications. (1989) (464)
Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. (1987) (450)
Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. (1985) (388)
Identification and Characterization of a Novel Related Adhesion Focal Tyrosine Kinase (RAFTK) from Megakaryocytes and Brain (*) (1995) (362)
HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. (1984) (353)
A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus (1989) (351)
Haematologic manifestations of the human immune deficiency virus (HIV) (1987) (349)
Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein. (1986) (347)
[Acquired immunodeficiency syndrome]. (1983) (346)
Recombinant human erythropoietin for patients with AIDS treated with zidovudine. (1990) (343)
Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy (2011) (338)
HTLV-III in cells cultured from semen of two patients with AIDS. (1984) (314)
Human T lymphotropic virus type III infection of human alveolar macrophages. (1986) (293)
Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. (1984) (291)
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. (1991) (282)
Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. (1984) (269)
Stromal cell-derived factor-1α stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C (2000) (268)
How Doctors Think (2007) (267)
Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. (1989) (252)
Chemokine Receptors CXCR-1/2 Activate Mitogen-activated Protein Kinase via the Epidermal Growth Factor Receptor in Ovarian Cancer Cells* (2000) (232)
SEROEPIDEMIOLOGICAL STUDIES OF HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN ACQUIRED IMMUNODEFICIENCY SYNDROME (1984) (231)
Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. (1985) (231)
HTLV-III IN SYMPTOM-FREE SERONEGATIVE PERSONS (1984) (224)
Suppression of in vitro haematopoiesis following human immunodeficiency virus infection (1987) (218)
A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. (1985) (200)
Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. (2001) (194)
Prolonged Zidovudine Therapy in Patients With AIDS and Advanced AIDS-Related Complex (1989) (193)
EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO (1985) (188)
The α-Chemokine Receptor CXCR4 Is Expressed on the Megakaryocytic Lineage From Progenitor to Platelets and Modulates Migration and Adhesion (1998) (188)
Stromal cell-derived factor-1 alpha and stem cell factor/kit ligand share signaling pathways in hemopoietic progenitors: a potential mechanism for cooperative induction of chemotaxis. (1998) (183)
HTLV-III infection among health care workers. Association with needle-stick injuries. (1985) (183)
Pathophysiology and management of HIV-associated hematologic disorders. (1989) (181)
Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus. (1989) (178)
Hematologic manifestations of the human immune deficiency virus (HIV). (1988) (172)
The pathogenesis of myelofibrosis in myeloproliferative disorders. (1980) (162)
Biological properties of a CD4 immunoadhesin (1990) (153)
Multicenter trial of low‐dose paclitaxel in patients with advanced AIDS‐related Kaposi sarcoma (2002) (147)
Pathogenesis of B cell lymphoma in a patient with AIDS. (1986) (146)
The histiocytic disorders: a pathophysiologic analysis. (1981) (145)
Δ9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo (2008) (145)
Beta-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK. (1998) (138)
Stimulation of β1 Integrin Induces Tyrosine Phosphorylation of Vascular Endothelial Growth Factor Receptor-3 and Modulates Cell Migration* (2001) (137)
Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. (1990) (135)
Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. (1995) (133)
A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. (1986) (130)
In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and gamma interferon. (1986) (126)
HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes. (2001) (125)
The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. (1998) (124)
Human Immunodeficiency Virus Tat Modulates the Flk-1/KDR Receptor, Mitogen-Activated Protein Kinases, and Components of Focal Adhesion in Kaposi’s Sarcoma Cells (1998) (123)
The Anatomy of Hope. (2004) (123)
Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. (1990) (120)
Untangling the Web--patients, doctors, and the Internet. (2010) (119)
Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. (1988) (118)
Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors. (1994) (116)
Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors (1994) (115)
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. (2006) (113)
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and Metastasis (2010) (113)
Physician Burnout, Interrupted. (2020) (110)
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa‐2a by intramuscular injection (1987) (108)
RAFTK, a Novel Member of the Focal Adhesion Kinase Family, Is Phosphorylated and Associates with Signaling Molecules upon Activation of Mature T Lymphocytes (1997) (107)
HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. (2000) (107)
Proliferation of astroglia and oligodendroglia in response to human T cell-derived factors. (1984) (105)
Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C. (2000) (103)
Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. (1983) (102)
Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells (1992) (101)
The Anatomy of Hope: How People Prevail in the Face of Illness (2003) (101)
Production of cytokines by peripheral blood monocytes/macrophages infected with human immunodeficiency virus type 1 (HIV-1). (1990) (100)
Extracellular matrix regulates endothelial functions through interaction of VEGFR‐3 and integrin α5β1 (2005) (100)
The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. A phase 1 study. (1990) (99)
Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. (2003) (98)
Anticardiolipin antibodies associated with HTLV‐III infection (1987) (98)
Hepatitis C Virus and HIV Envelope Proteins Collaboratively Mediate Interleukin-8 Secretion through Activation of p38 MAP Kinase and SHP2 in Hepatocytes* (2003) (95)
β-Chemokine Receptor CCR5 Signals through SHP1, SHP2, and Syk* (2000) (94)
ANTICARDIOLIPIN ANTIBODIES ASSOCIATED WITH HTLV‐III INFECTION (1988) (94)
Human immunodeficiency virus does not induce interleukin-1, interleukin-6, or tumor necrosis factor in mononuclear cells (1990) (93)
Biology and therapy of Kaposi's sarcoma. (1984) (93)
Interaction of human bone marrow fibroblasts with megakaryocytes: role of the c-kit ligand. (1992) (92)
Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group. (1987) (92)
Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. (1986) (90)
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. (1989) (89)
Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men. (1986) (89)
Cytokine production by primary bone marrow megakaryocytes. (1994) (85)
Immune (γ) interferon produced by a human T-lymphoblast cell line (1981) (82)
Characterization of adhesive interactions between human endothelial cells and megakaryocytes. (1993) (81)
Identification and characterization of a novel tyrosine kinase from megakaryocytes. (1994) (80)
Fatigue in cancer and HIV/AIDS. (1998) (80)
Medical care costs of AIDS in Massachusetts. (1986) (79)
Activation of Vascular Endothelial Growth Factor Receptor-3 and Its Downstream Signaling Promote Cell Survival under Oxidative Stress* (2004) (79)
Factors affecting cellular tropism of human immunodeficiency virus (1990) (75)
Low sensitivity of ELISA testing in early HIV infection. (1986) (72)
Off the record--avoiding the pitfalls of going electronic. (2008) (72)
Human immunodeficiency virus infection of megakaryocytic cells. (1991) (72)
Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. (1997) (71)
Cloning and characterization of HTK, a novel transmembrane tyrosine kinase of the EPH subfamily. (1994) (70)
Keeping the patient in the equation--humanism and health care reform. (2009) (70)
Association of Csk-homologous Kinase (CHK) (formerly MATK) with HER-2/ErbB-2 in Breast Cancer Cells* (1997) (70)
Styryl sulfonyl compounds inhibit translation of cyclin D1 in mantle cell lymphoma cells (2009) (70)
Natural and biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro. (1982) (67)
Kaposi's Sarcoma-associated Herpesvirus-encoded G Protein-coupled Receptor Activation of c-Jun Amino-terminal Kinase/Stress-activated Protein Kinase and Lyn Kinase Is Mediated by Related Adhesion Focal Tyrosine Kinase/Proline-rich Tyrosine Kinase 2* (1999) (67)
Granulocyte-macrophage colony-stimulating factor mitigates the neutropenia of combined interferon alfa and zidovudine treatment of acquired immune deficiency syndrome-associated Kaposi's sarcoma. (1991) (67)
CD4+ lymphocyte function with early human immunodeficiency virus infection. (1989) (65)
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. (2000) (64)
Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. (1994) (64)
Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction. (1992) (64)
Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4 (1989) (64)
Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. (1995) (63)
Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin alpha5beta1. (2005) (61)
Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston. (1985) (60)
Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. (1993) (60)
HIV-1 Tat Induces Microvascular Endothelial Apoptosis Through Caspase Activation1 (2001) (60)
Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. (1986) (59)
Serological characterization of HTLV-III infection in AIDS and related disorders. (1986) (57)
Salivary antibodies as a means of detecting human T cell lymphotropic virus type III/lymphadenopathy-associated virus infection (1986) (56)
Phase I study of 2'-3'-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine. (1991) (55)
Money and the changing culture of medicine. (2009) (55)
Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. (1992) (54)
Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders. (1985) (54)
HIV Nef Inhibits T Cell Migration* (2002) (54)
Your Medical Mind: How to Decide What Is Right for You (2011) (53)
The new language of medicine. (2011) (52)
Human kit ligand (stem cell factor) modulates platelet activation in vitro. (1994) (52)
The related adhesion focal tyrosine kinase (RAFTK) is tyrosine phosphorylated and participates in colony-stimulating factor-1/macrophage colony-stimulating factor signaling in monocyte-macrophages. (1998) (50)
Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma (2002) (50)
Update: evaluation of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection in health-care personnel--United States. (1985) (50)
Infection of nonlymphoid cells by human immunodeficiency virus type 1 or type 2 (1990) (50)
Virologic studies in a case of transfusion-associated AIDS. (1984) (49)
Acute hyperparathyroidism with systemic calcinosis. Report of a case. (1989) (49)
Interferon-α2a in the Treatment of Acquired Immunodeficiency Syndrome-Related Kaposi's Sarcoma (1991) (48)
Management of the hematologic complications of human immunodeficiency virus infection. (1990) (48)
Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex. (1991) (47)
Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. (2006) (47)
HTLV-I-SPECIFIC ANTIBODY IN AIDS PATIENTS AND OTHERS AT RISK (1984) (46)
Serodiagnosis of Antibodies to the Human AIDS Retrovirus with a Bacterially Synthesized env Polypeptide (1986) (45)
Medical Taylorism. (2016) (44)
Interferon therapy for Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS) (1989) (44)
Immunogenic nature of a Pol gene product of HTLV-III/LAV. (1987) (43)
c-Src Mediates Mitogenic Signals and Associates with Cytoskeletal Proteins upon Vascular Endothelial Growth Factor Stimulation in Kaposi’s Sarcoma Cells1 (2000) (42)
Current advances in the diagnosis and treatment of AIDS: an introduction. (1990) (42)
Behavioral risk factors for HIV infection among homosexual men at a Boston community health center. (1988) (41)
Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160 (1989) (41)
Structural proteins of Hepatitis C virus induce interleukin 8 production and apoptosis in human endothelial cells. (2005) (41)
Biology and therapy of epidemic Kaposi's sarcoma (1987) (41)
Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection* (2005) (41)
Activation of the Connective Tissue Growth Factor (CTGF)-Transforming Growth Factor β 1 (TGF-β 1) Axis in Hepatitis C Virus-Expressing Hepatocytes (2012) (39)
Characterization of Serum Netralization Response to the Human Immunodeficiency Virus (HIV) (1987) (38)
Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery (1991) (38)
Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons. (1986) (38)
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway (2014) (37)
The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors (1994) (36)
The acquired immunodeficiency syndrome. (1983) (36)
Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsets. (1985) (36)
Slit2/Robo4 Signaling Modulates HIV-1 gp120-Induced Lymphatic Hyperpermeability (2011) (36)
Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent. (1985) (35)
CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells (1990) (34)
A phase I study of recombinant human interleukin‐2 and alpha‐interferon‐2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma (1990) (33)
Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium. (2012) (33)
Characterization of signal transduction pathways in human bone marrow endothelial cells. (1997) (32)
Signal transduction in human hematopoietic cells by vascular endothelial growth factor related protein, a novel ligand for the FLT4 receptor. (1997) (31)
Correlation of enzyme-linked immunosorbent assays for serum human immunodeficiency virus antigen and antibodies to recombinant viral proteins with subsequent clinical outcomes in a cohort of asymptomatic homosexual men. (1987) (31)
Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. (1990) (31)
Acute leukemia: biology and treatment. (1979) (30)
Lymphokines secreted by an established lymphocyte line modulate receptor-mediated endocytosis in macrophages derived from human monocytes. (1983) (30)
Neoplasms in the acquired immune deficiency syndrome: the multidisciplinary approach to treatment. (1987) (30)
Inhibition of serum-enhanced HIV-1 infection of U937 monocytoid cells by recombinant soluble CD4 and anti-CD4 monoclonal antibody. (1990) (29)
Characterization of Signal Transduction Pathways in Human Bone Marrow Endothelial Cells (1997) (29)
CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor. (1999) (29)
Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization. (2011) (28)
GM‐CSF as an Alternative to Dose Modification of the Combination Zidovudine and Interferon-α in the Treatment of AIDS‐Associated Kaposi's Sarcoma (1991) (28)
Use of IFN-gamma in patients with AIDS. (1990) (28)
Hematopoietic growth factors in AIDS. (1992) (28)
Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. (2005) (27)
Lack of evidence of prolonged human immunodeficiency virus infection before antibody seroconversion. (1988) (27)
Hairy cell leukemia. Disease pattern and prognosis (1984) (27)
The ultrastructural and immunohistochemical demonstration of viral particles in lymph nodes from human immunodeficiency virus-related and non-human immunodeficiency virus-related lymphadenopathy syndromes. (1988) (26)
Cannabinoid modulation of Kaposi's sarcoma-associated herpesvirus infection and transformation. (2007) (26)
There is more to life than death. (2012) (26)
Phase 1 study of recombinant human CD4-immunoglobulin G therapy of patients with AIDS and AIDS-related complex (1991) (26)
Measurement of aflatoxin B1, its metabolites, and DNA adducts by synchronous fluorescence spectrophotometry. (1986) (25)
Phase II study of recombinant alpha-interferon in malignant melanoma. (1990) (25)
Apparent transmission of human T-cell leukemia virus type III to a heterosexual woman with the acquired immunodeficiency syndrome. (1985) (25)
Cytokine gene expression and synthesis by human megakaryocytic cells. (1992) (25)
Slit2N/Robo1 Inhibit HIV-gp120-Induced Migration and Podosome Formation in Immature Dendritic Cells by Sequestering LSP1 and WASp (2012) (24)
Long-term follow-up of didanosine administered orally twice daily to patients with advanced human immunodeficiency virus infection and hematologic intolerance of zidovudine. (1993) (24)
Epidemic of the acquired immunodeficiency syndrome: a need for economic and social planning. (1983) (23)
Characterization of serum neutralization response to the human immunodeficiency virus (HIV). (1987) (23)
Bone marrow toxicity of dideoxyinosine. (1989) (23)
Kaposi's sarcoma: an oncologic looking glass (1982) (23)
Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector (1997) (23)
Zidovudine intolerance. (1990) (23)
Hematopoietic growth factors: From methylcellulose to man (1987) (22)
HTLV-III/LAV infection in kidney and liver transplantation. (1987) (22)
Evaluation of novel cell cycle inhibitors in mantle cell lymphoma (2007) (21)
A strategy for hope: a commentary on necessary collusion. (2005) (21)
Methamphetamine functions as a novel CD4+ T-cell activator via the sigma-1 receptor to enhance HIV-1 infection (2019) (20)
Why 'quality' care is dangerous. (2009) (19)
Second Opinions: Stories of Intuition and Choice in a Changing World of Medicine (2000) (19)
Effects of transforming growth factor beta on megakaryocytic cell fusion and endomitosis. (1992) (19)
Potent Inhibition of Human Immunodeficiency Virus Type 1 in Primary T Cells and Alveolar Macrophages by a Combination Anti-Rev Strategy Delivered in an Adeno-Associated Virus Vector (1998) (19)
God at the bedside. (2004) (18)
Increased suppressor T cells in probable transmitters of human immunodeficiency virus infection. (1989) (18)
Human Immunodeficiency Virus Infection in Hemodialysis Patients (1988) (17)
The Power of Regret. (2017) (17)
Effect of intravenous recombinant gamma-interferon on the respiratory burst of blood monocytes from patients with AIDS. (1986) (17)
Sipple's syndrome with a malignant pheochromocytoma presenting as a pericardial effusion. (1978) (17)
Stimulation of human immunodeficiency virus type 1 expression by ceramide. (1994) (17)
Impact of transfusion on viral load in human immunodeficiency virus infection. (1997) (16)
Acquired immune deficiency syndrome: AIDS: the widening gyre (1983) (16)
The regulation of megakaryocytopoiesis. (1995) (15)
Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells. (1993) (15)
Transfusion associated AIDS. (1988) (15)
Isolation of HTLV-III from CSF and neural tissues of patients with AIDS-related neurological syndromes (1987) (15)
A phase I study of an outpatient regimen of recombinant human interleukin‐2 and alpha‐2a‐interferon in patients with solid tumors (1991) (15)
Correction: Slit2/Robo4 Signaling Modulates HIV-1 gp120-Induced Lymphatic Hyperpermeability (2012) (14)
Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. (1991) (14)
The right to a trial: Should dying patients have access to experimental drugs? (2006) (13)
Cocaine Enhances DC to T-cell HIV-1 Transmission by Activating DC-SIGN/LARG/LSP1 Complex and Facilitating Infectious Synapse Formation (2017) (13)
Status of colony-stimulating factors in cancer and AIDS. (1990) (13)
Colony-stimulating factors: present status and future applications. (1988) (12)
Nucleoside therapy for HIV infection--some answers, many questions. (1992) (12)
Slit2N Inhibits Transmission of HIV-1 from Dendritic Cells to T-cells by Modulating Novel Cytoskeletal Elements (2013) (12)
Identification of a novel human immunodeficiency virus strain cytopathic to megakaryocytic cells (1993) (12)
In vitro effects of stem‐cell factor or interleukin‐3 on myelosuppression associated with AIDS (1994) (11)
Hairy cell leukemia. Disease pattern and prognosis. (1984) (11)
Differential effects of interleukin-13 on cytomegalovirus and human immunodeficiency virus infection in human alveolar macrophages. (1997) (11)
Antiretroviral therapy and immunomodulators in patients with AIDS. (1991) (11)
Hemophilus parainfluenzae prostatitis in a homosexual man with chronic lymphadenopathy syndrome and HTLV-III infection. (1987) (11)
The Measure of Our Days: New beginnings at life's end (1997) (10)
Therapeutic options in hairy-cell leukemia. (1985) (10)
Methamphetamine Enhances HIV-1 Replication in CD4+ T-Cells via a Novel IL-1β Auto-Regulatory Loop (2020) (10)
Endocannabinoids are expressed in bone marrow stromal niches and play a role in interactions of hematopoietic stem and progenitor cells with the bone marrow microenvironment. (2011) (10)
Human immunodeficiency virus infection of megakaryocytic cells (1991) (9)
Endocannabinoids Are Expressed in Bone Marrow Stromal Niches and Play a Role in Interactions of Hematopoietic Stem and Progenitor Cells with the Bone Marrow Microenvironment* (2010) (9)
Immune (gamma) interferon produced by a human T-lymphoblast cell line. (1981) (8)
Clinical applications of colony-stimulating factors. (1988) (8)
CD 4 ' lymphocyte function with early human immunodeficiency virus infection ( AIDS-related complex / gp 120 / soluble CD 4 ) (8)
Transfusion in HIV disease (1997) (8)
A MULTICENTER, PHASE II/III STUDY OF ATRAGEN™ (Tretinoin Liposomal) IN PATIENTS WITH AIDS-ASSOCIATED KAPOSI'S SARCOMA: 14 (1997) (8)
Underlying Pathophysiology of HCV Infection in HIV-Positive Drug Users (2008) (8)
LOW DOSE PACLITAXEL (TAXOL⊙) IS HIGHLY EFFECTIVE IN THE TREATMENT OF PATIENTS WITH ADVANCED AIDS-RELATED KAPOSI'S SARCOMA: 77 (1997) (7)
TUMOUR INFILTRATES IN ACQUIRED IMMUNODEFICIENCY SYNDROME PATIENTS WITH KAPOSI'S SARCOMA (1983) (7)
AIDS-related Kaposi's sarcoma: therapeutic modalities. (1987) (7)
Causation of AIDS revealed (1984) (7)
Clinical spectrum of HTLV-III in humans. (1985) (7)
ISOLATION OF HUMAN IMMUNODEFICIENCY VIRUS AND SERUM NEUTRALISING ANTIBODY (1986) (7)
Viruses and human neoplasia. Approaching etiology. (1983) (7)
Medical Taylorism, Lean, and Toyota. (2016) (7)
HCV and HIV envelope proteins collaboratively mediate IL-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes (2003) (7)
Phase II Study of Recombinant α‐Interferon in Malignant Melanoma (1990) (7)
Acquired immunodeficiency syndrome: The AIDS epidemic: continental drift (1984) (6)
Treatment of AIDS with combinations of antiretroviral agents: a summary. (1991) (6)
Oral 9-cis-Retinoic Acid is active in AIDS related Kaposi's sarcoma: AIDS Associated Malignancy Consortium Study 002 (1998) (6)
Beta-chemokine induction of activation protein-1 and cyclic AMP responsive element activation in human myeloid cells. (2001) (6)
Granulocyte-macrophage colony-stimulating factor in human immunodeficiency virus disease. (1990) (5)
Expression and utilization of co-receptors in HIV and simian immunodeficiency virus infection of megakaryocytes. (1999) (5)
A great case. (2004) (5)
Cocaine enhances HIV-1 gp120-induced lymphatic endothelial dysfunction in the lung (2015) (5)
Thrombopoiesis: Capturing the unicorn (1994) (4)
Kaposi's Sarcoma: Why a ‘Homosexual Disease’? (1982) (4)
ON 01910.Na Suppresses Cyclin D1 Accumulation in trisomy 8 Myelodysplastic Syndromes Patients While Decreasing Bone Marrow CD34+ Blast Counts and Aneuploid Clone Size. (2009) (4)
IGA DEFICIENCY AND SALIVARY TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS (1986) (4)
Surgical approach to generalized lymphadenopathy in homosexual men (1987) (4)
Combined Administration of Rituximab and ON 013105 Induces Apoptosis in Mantle Cell Lymphoma Cells and Reduces Tumor Burden in a Mouse Model of Mantle Cell Lymphoma (2012) (4)
Buying a cure: what business know-how can do for disease. (2008) (4)
Oral vinzolidine as therapy for Kaposi's sarcoma and carcinomas of lung, breast, and colon/rectum (2004) (4)
Retroviral infection and haemopoiesis. (2007) (3)
Therapeutic Discovery Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy (2011) (3)
Scratching the surface (1991) (3)
Pulmonary hypertrophic osteoarthropathy as the initial manifestation of interstitial fibrosis. (1989) (3)
Therapy of epidemic Kaposi's sarcoma. (1986) (3)
Zidovudine intolerance. Discussion (1990) (3)
Acquired immunodeficiency syndrome: Laying the groundwork for neutralizing AIDS-linked virus (1985) (3)
Clinical symptomatology of the acquired immunodeficiency syndrome (AIDS) and related disorders. (1986) (3)
Synergistic Effects of a Novel Water-Soluble Small Molecule, ON 013105, and Rituximab on Mantle Cell Lymphoma In Vitro and In Vivo (2010) (2)
The moral way to pay for human organs. (1999) (2)
Erratum: Quantitation of plasma human immunodeficiency virus type 1 RNA by competitive polymerase chain reaction (J Infect Dis (1992) 165 (1119-1123)) (1993) (2)
Slit 2 N / Robo 1 Inhibit HIV-gp 120-Induced Migration and Podosome Formation in Immature Dendritic Cells by Sequestering LSP 1 and WASp (2012) (2)
Hepatitis from isoniazid and rifampin. (1978) (2)
Δ-9 Tetrahydrocannabinol inhibits growth and metastasis of lung cancer. (2007) (2)
Mechanisms of action and therapeutic applications of biologicals in cancer and immune deficiency disorders : proceedings of a Hoffmann-La Roche-Smith Kline & French-UCLA symposium, held at Keystone, Colorado, April 23-30, 1988 (1989) (2)
Production of gamma (immune) interferon by a permanent human T-lymphocyte cell line. (1984) (2)
Of mice, monkeys and men (1991) (2)
The new language of medicine. (2012) (2)
Endogenous Cannabinoid-Like Arachidonoyl Serine Induces Angiogenesis through Novel Pathways. (2005) (2)
That buzzing sound: the mystery of tinnitus. (2009) (2)
Recombinant Human Erythropoietin in the Treatment of Anemia Associated with Human Immunodeficiency Virus (HIV) Infection and Zidovudine Therapy (2020) (2)
The AIDS epidemic: continental drift. (1984) (2)
Human Herpesvirus-8 (HHV-8/KSHV) Induces Reactive Oxygen Species in Endothelial Cells That Facilitate Virus Infection. (2004) (2)
Tumor infiltrates in acquired immunodeficiency syndrome patients with Kaposi's sarcoma. (1983) (1)
Crybabies: solving the colic conundrum. (2007) (1)
Effect of recombinant soluble CD4 on the in vitro growth of hematopoietic progenitor cells from AIDS patients. (1990) (1)
The plastic panic: how worried should we be about everyday chemicals? (2010) (1)
Suramin therapy in AIDS and related diseases: initial report of the U.S. Suramin Working Group [abstract] (1986) (1)
Holding cell: why the cloning decision was wrong. (2002) (1)
AIDS: questions and controversies--a panel discussion. (1987) (1)
Endogenous Cannabinoid-Like Arachidonoyl Serine Protects Against LPS-Induced Endothelial Apoptosis. (2006) (1)
role of the c-kit ligand Interaction of human bone marrow fibroblasts with megakaryocytes: (2011) (1)
In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and y interferon ( U-937 cells ) (1999) (1)
Acquired immune deficiency syndrome : proceedings of a Schering Corp.-UCLA Symposium held in Park City, Utah, February 5-10, 1984 (1984) (1)
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway (2014) (1)
HCV and HIV Envelope Proteins Co-Operatively Induce Fas-Mediated Apoptosis Via a Novel Stat1 Signaling Pathway. (2004) (1)
Acquired immune deficiency syndrome (1984) (1)
Expression andImmunogenicity oftheExtracellular Domain oftheHumanImmunodeficiency VirusType1 Envelope Glycoprotein, gpl60 (1989) (1)
New directions in hematologic biotherapy. (1989) (1)
Apoptosis and Autophagy Cancer Cells by Coordinating the Cross-talk between Cannabidiol Induces Programmed Cell Death in Breast (2011) (1)
We’re Not Leaving: 9/11 Responders Tell Their Stories of Courage, Sacrifice, and Renewal (2011) (1)
God at the bedside. (2019) (1)
Detection of rare cells expressing HTLV-III in primary lymphoid tissue from infected individuals using a highly sensitive in situ hybridization method (1986) (1)
Retroviral vaccines: How close is C to D? (1986) (1)
AIDS. Of mice, monkeys and men. (1991) (1)
Langerhans cell (eosinophilic) granulomatosis (1992) (1)
Acquired immunodeficiency syndrome. Introduction. (1984) (0)
The challenge of combination antiretroviral therapy for AIDS. An introduction. (1991) (0)
Cannabinoid Receptors CB1 and CB2 Regulate Mobilization of Hematopoietic Stem and Progenitor Cells. (2008) (0)
Evaluation of Novel Cell Cycle Inhibitors in Mantle Cell Lymphoma. (2006) (0)
Pathobiology of HTLV-III/LAV In Human Monocyte-Macrophage (1990) (0)
Purified recombinant CD4 inhibits HIV-1 infection of peripheral blood macrophages. (1991) (0)
T.B. or not T.B.? (1993) (0)
The Structural Basis for the Role of CHK as a Tumor Suppressor Protein in Human Breast Cancer (2002) (0)
Phase1StudyofRecombinant HumanCD4-Immunoglobulin G Therapy ofPatients withAIDSandAIDS-Related Complex (1991) (0)
Watch – The Webmaster Changing your mind (0)
followed by transmigration of monocytes HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion (2001) (0)
The meaning in suffering Marc Flitter South Royalton (1998) (0)
HIV Envelope Protein gp120 Stimulates Expression of Specific Chemokines in Lymphatic Endothelial Cells. (2004) (0)
The Potential Role of Delta(9)-Tetrahydrocannabinol in the Pathogenesis of Kaposi’s Sarcoma. (2005) (0)
The peanut puzzle: could the conventional wisdom on children and allergies be wrong? (2011) (0)
Book Review Cancer, HIV and AIDS (Cancer Surveys. Vol. 10.) Edited by V. Beral, H.W. Jane, and R.A. Weiss. 171 pp., illustrated. Plainview, N.Y., Cold Spring Harbor Laboratory Press, 1991. $60. (1992) (0)
Open channels: Do new cystic-fibrosis therapies hold the key to treating other genetic disorders? (2009) (0)
Introduction (0)
Scratching the surface Evidence is rapidly emerging of the part played by the ligand for the receptor encoded by the proto-oncogene c-kit in hematopoietic cell proliferation. (1991) (0)
CHARACTERIZATION OF CYTOKINE INDUCED SIGNALING EVENTS IN KAPOSI'S SARCOMA: 47 (1997) (0)
DAMD 1790-C-0106 TITLE : PATHOBIOL , f OF HIV IN THE HUMAN MONOCYTE-MACROPHAGE PRINCIPAL INVESTIGATOR : (0)
Why Political Scientists Aren't Public (2016) (0)
Recruitment in a Two-Stage Phase II Trial of AIDS Kaposi's Sarcoma Patients (1998) (0)
GAMMA (IMMUNE) INTERFERON PRODUCTION BY A PERMANENT HUMAN T-LYMPHOCYTE CELL LINE (1982) (0)
Molecular Mechanism of Nef-Mediated Inhibition of T Cell Migration in Response to SDF-1α. (2004) (0)
Molecular Characterization of the Cannabinoid-Mediated Migration of Monocytes. (2005) (0)
Apoptosis Through Caspase Activation HIV-1 Tat Induces Microvascular Endothelial (2001) (0)
Cannabinoids Inhibit the CXCL12-Induced Migration of T Lymphocytes. (2004) (0)
Designing babies: genetic manipulation has just led to the birth of an Alzheimer's-free baby. Is this a step toward a 'Brave New World'? or a needed medical advance? (2002) (0)
Book Review Viruses and Bone Marrow: Basic Research and Clinical Practice (Hematology. Vol. 16.) Edited by Neal S. Young. 446 pp., illustrated. New York, Marcel Dekker, 1993. $159. 0-8247-8833-8 (1993) (0)
The destiny that lurks in our DNA. (1998) (0)
Much progress, still many challenges. (2012) (0)
Jerome Groopman. (2004) (0)
Methamphetamine functions as a novel CD4+ T-cell activator via the sigma-1 receptor to enhance HIV-1 infection (2019) (0)
Modulation of Myeloid and Megakaryocytic Progenitor Cells by a Novel B-Glucan and GM-CSF (1995) (0)
Other voices. Should money drive everything? (2009) (0)
Transfusion-acquired HIV infection among immunocompromised hosts. (1987) (0)
The use of growth hematopoietic factors in AIDS. (1992) (0)
Erratum: Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector (Journal of Virology 71:5 (4071-4078)) (1998) (0)
The new language of medicine. (2011) (0)
Translating molecular targets for chemoprevention into interventions for at-risk populations (2007) (0)
Kinase homologue csk (chk) utilisee dans la detection et le traitement du cancer du sein (1998) (0)
When Experts Disagree: The Art of Medical Decision Making (2013) (0)
The Best of the Best American Science Writing (2010) (0)
Letter from Mark H. Kaplan, Jerome E. Groopman, Sheldon H. Landesman, Leon D. Epstein, Steven Marlowe, North Shore University Hospital to Harold Varmus (1985) (0)
Lignee de megacaryocytes differencies produisant de nouveaux facteurs de differenciation de megacaryocytes (1992) (0)
COMM ENTARY Much progress , still many challenges (2012) (0)
p38 MAP kinase mediates CTGF expression in Huh7.5-FL cells. (2013) (0)
Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. (1989) (0)
Interview with Jerome E. Groopman and Pamela Hartzband (2013) (0)
Adhesion in Kaposi's Sarcoma Cells Protein Kinases, and Components of Focal the Flk-1/KDR Receptor, Mitogen-Activated Human Immunodeficiency Virus Tat Modulates (2013) (0)
Human retroviruses : proceedings of a Chimertech-UCLA Symposium held at Tamarron, Colorado, February 4-11, 1989 (1990) (0)
Pathobiology of HIV in the Human Monocyte-Macrophage (1993) (0)
Mechanism of hepatitis c virus-like particle-induced apoptosis in huvec (2000) (0)
Stimulation in Kaposi's Sarcoma Cells Vascular Endothelial Growth Factor Associates with Cytoskeletal Proteins upon c-Src Mediates Mitogenic Signals and (2000) (0)
Physician writers (2004) (0)
Vascular endothelial growth factor inhibits lipopolysaccharide-induced apoptosis of endothelial cells (2000) (0)
Human T-lymphotropic virus type III infection in previously immunocompromised hosts. (1986) (0)
Growth factors. (1980) (0)
before antibody seroconversion Lack of evidence of prolonged human immunodeficiency virus infection (2011) (0)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-1989. A 34-year-old Jamaican man with fever, hepatic failure, diarrhea, and a progressive gait disorder. (1989) (0)
Delta (9)-Tetrahydrocannabinol Contributes to the Development of Kaposi’s Sarcoma. (2006) (0)

This paper list is powered by the following services:

Other Resources About Jerome Groopman

en.wikipedia.org

What Schools Are Affiliated With Jerome Groopman?

Jerome Groopman is affiliated with the following schools:

What Are Jerome Groopman's Academic Contributions?

Jerome Groopman has made the following academic contributions:

The Measure of Our Days